BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22080085)

  • 1. NADPH oxidase-dependent oxidative stress in the failing heart: From pathogenic roles to therapeutic approach.
    Octavia Y; Brunner-La Rocca HP; Moens AL
    Free Radic Biol Med; 2012 Jan; 52(2):291-7. PubMed ID: 22080085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of NADPH oxidases in cardiac remodelling and heart failure.
    Sirker A; Zhang M; Murdoch C; Shah AM
    Am J Nephrol; 2007; 27(6):649-60. PubMed ID: 17901689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of NADPH oxidase reduces myocardial oxidative stress and apoptosis and improves cardiac function in heart failure after myocardial infarction.
    Qin F; Simeone M; Patel R
    Free Radic Biol Med; 2007 Jul; 43(2):271-81. PubMed ID: 17603936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NADPH oxidase and heart failure.
    Murdoch CE; Grieve DJ; Cave AC; Looi YH; Shah AM
    Curr Opin Pharmacol; 2006 Apr; 6(2):148-53. PubMed ID: 16483850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.
    Paravicini TM; Touyz RM
    Diabetes Care; 2008 Feb; 31 Suppl 2():S170-80. PubMed ID: 18227481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure.
    Murdoch CE; Zhang M; Cave AC; Shah AM
    Cardiovasc Res; 2006 Jul; 71(2):208-15. PubMed ID: 16631149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular NADPH oxidases as drug targets for novel antioxidant strategies.
    Guzik TJ; Harrison DG
    Drug Discov Today; 2006 Jun; 11(11-12):524-33. PubMed ID: 16713904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NADPH oxidase hyperactivity induces plantaris atrophy in heart failure rats.
    Bechara LR; Moreira JB; Jannig PR; Voltarelli VA; Dourado PM; Vasconcelos AR; Scavone C; Ramires PR; Brum PC
    Int J Cardiol; 2014 Aug; 175(3):499-507. PubMed ID: 25023789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactive oxygen species and vascular biology: implications in human hypertension.
    Touyz RM; Briones AM
    Hypertens Res; 2011 Jan; 34(1):5-14. PubMed ID: 20981034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NADPH oxidase-dependent redox signaling in human heart failure: relationship between the left and right ventricle.
    Nediani C; Borchi E; Giordano C; Baruzzo S; Ponziani V; Sebastiani M; Nassi P; Mugelli A; d'Amati G; Cerbai E
    J Mol Cell Cardiol; 2007 Apr; 42(4):826-34. PubMed ID: 17346742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressing NADPH oxidase-dependent oxidative stress in the vasculature with nitric oxide donors.
    Selemidis S
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1395-401. PubMed ID: 18954334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy.
    Minhas KM; Saraiva RM; Schuleri KH; Lehrke S; Zheng M; Saliaris AP; Berry CE; Barouch LA; Vandegaer KM; Li D; Hare JM
    Circ Res; 2006 Feb; 98(2):271-9. PubMed ID: 16357304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NADPH oxidase and uncoupled nitric oxide synthase are major sources of reactive oxygen species in oral squamous cell carcinoma. Potential implications for immune regulation in high oxidative stress conditions.
    Czesnikiewicz-Guzik M; Lorkowska B; Zapala J; Czajka M; Szuta M; Loster B; Guzik TJ; Korbut R
    J Physiol Pharmacol; 2008 Mar; 59(1):139-52. PubMed ID: 18441394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure.
    Nishio M; Sakata Y; Mano T; Yoshida J; Ohtani T; Takeda Y; Miwa T; Masuyama T; Yamamoto K; Hori M
    J Hypertens; 2007 Feb; 25(2):455-61. PubMed ID: 17211254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the myocardial redox state by vagal nerve stimulation after experimental myocardial infarction.
    Tsutsumi T; Ide T; Yamato M; Kudou W; Andou M; Hirooka Y; Utsumi H; Tsutsui H; Sunagawa K
    Cardiovasc Res; 2008 Mar; 77(4):713-21. PubMed ID: 18065771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of NOX2 (gp91phox) prevents oxidative stress and progression to advanced heart failure.
    Parajuli N; Patel VB; Wang W; Basu R; Oudit GY
    Clin Sci (Lond); 2014 Sep; 127(5):331-40. PubMed ID: 24624929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PKC-delta-dependent activation of oxidative stress in adipocytes of obese and insulin-resistant mice: role for NADPH oxidase.
    Talior I; Tennenbaum T; Kuroki T; Eldar-Finkelman H
    Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E405-11. PubMed ID: 15507533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox signalling involving NADPH oxidase-derived reactive oxygen species.
    Dworakowski R; Anilkumar N; Zhang M; Shah AM
    Biochem Soc Trans; 2006 Nov; 34(Pt 5):960-4. PubMed ID: 17052237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress and heart failure.
    Byrne JA; Grieve DJ; Cave AC; Shah AM
    Arch Mal Coeur Vaiss; 2003 Mar; 96(3):214-21. PubMed ID: 12722552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition.
    Selemidis S; Sobey CG; Wingler K; Schmidt HH; Drummond GR
    Pharmacol Ther; 2008 Dec; 120(3):254-91. PubMed ID: 18804121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.